[1] Gakidou E,Nordhagen S,Obermeyer Z.Coverage of cervical cancer screening in 57 countries:low average levels and large inequalities[J]. PLoS Med, 2008,5(6):863-868.
[2] 陈万青,张思维,曾红梅,等. 中国2010年恶性肿瘤发病与死亡[J].中国肿瘤,2014,23(1):1-10.
[3] Li J.Review of the cervical cancer disease burden in mainland China[J]. Asian Pac J Cancer Prev, 2011,12(5):1149-1153.
[4] Klingelhutz AJ,Foster SA,McDougall JK.Telomerase activation by the E6 geneproduct of human papillomavirus type 16[J]. Nature, 1996,380(6569):79-82.
[5] Wong VS,Kawamoto CT.Understanding cervical cancer prevention and screening in Chuukese women in Hawaii[J]. Hawaii Med J, 2010,69(6 Suppl 3):13-16.
[6] 何美,杜佳,赵方辉,等. 城市女性宫颈癌机会性筛查接受障碍原因及影响因素[J].中国公共卫生,2017,33(8):1166-1169.
[7] 管文燕,柏涛,郑金榆,等.高危型人乳头瘤病毒 DNA 检测在南京地区10221例宫颈癌前病变筛查中的应用效果分析[J].临床肿瘤学杂志, 2017,22(3):232-237. |
2018, Vol. 35 
